Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma

Autor: Xiaolei Wang, Shaoyan Liu, Zong-Min Zhang, Hui Huang, Zhen-Gang Xu, Song Ni
Rok vydání: 2017
Předmět:
Adult
Male
medicine.medical_specialty
Time Factors
Adolescent
medicine.medical_treatment
surgical treatment
Observational Study
030209 endocrinology & metabolism
Thyroid Lobectomy
Kaplan-Meier Estimate
Disease-Free Survival
Thyroid carcinoma
03 medical and health sciences
Young Adult
0302 clinical medicine
Risk Factors
medicine
Carcinoma
Humans
Thyroid Neoplasms
Survival rate
Aged
Proportional Hazards Models
Retrospective Studies
Completion thyroidectomy
business.industry
Hazard ratio
Thyroid
Thyroidectomy
General Medicine
Middle Aged
multifocality
medicine.disease
Prognosis
Carcinoma
Papillary

Surgery
medicine.anatomical_structure
Treatment Outcome
030220 oncology & carcinogenesis
Multivariate Analysis
papillary thyroid carcinoma
Female
Neoplasm Recurrence
Local

business
Follow-Up Studies
Research Article
Zdroj: Medicine
ISSN: 1536-5964
Popis: The National Comprehensive Cancer Network (NCCN) guidelines recommend completion thyroidectomy for patients with multifocal papillary thyroid carcinoma (PTC) diagnosed by paraffin pathology after lobectomy. However, studies for the influence of surgical range on prognosis of unilateral multifocal carcinoma are scarce. We analyzed the clinicopathological characteristics and long-term outcomes of patients with unilateral multifocal PTC to identify risk factors for recurrence and disease-related death. The clinical and pathological data of 123 cases with multifocal lesions in the unilateral thyroid lobe were retrospectively collected, including sex, age, stage, surgical range, histopathology characteristics, and follow-up data. The prognostic factors were analyzed by means of the Kaplan–Meier method. The recurrence in the contralateral residual thyroid was observed in 6 cases. The 10-year cumulative recurrence rate of the remnant thyroid was 7.0%. Extrathyroidal extension (ETE) was a significant prognostic factor, with χ2 equal to 4.043 and a P value of .044. One patient died from progression of pulmonary metastasis during the follow-up. The 10-year disease-specific survival rate was 96% and 14 cases experienced recurrences and underwent a second surgery (11.4%), and thus the 10-year recurrence-free survival rate was 83.2%. Multivariate analysis showed that the pathologic tumor (pT) stage was an independent prognostic factor for the recurrence-free survival rate (P
Databáze: OpenAIRE